Type 2 Diabetes: Clinical Trials

2,587 trials for Type 2 Diabetes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1589 completed, 346 unknown, 250 recruiting, 114 terminated. 1208 Not applicable, 279 Phase 3, 277 Phase 4, 234 Phase 2, 220 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1208Completed 711, Unknown 166, Recruiting 136, Not yet recruiting 55, Active not recruiting 52, Terminated 44, Withdrawn 28, Enrolling by invitation 13, Suspended 3
Phase 3279Completed 192, Unknown 22, Terminated 21, Recruiting 17, Active not recruiting 11, Not yet recruiting 9, Withdrawn 5, Suspended 2
Phase 4277Completed 168, Unknown 55, Recruiting 16, Terminated 13, Withdrawn 9, Not yet recruiting 8, Active not recruiting 5, Suspended 2, Enrolling by invitation 1
Phase 2234Completed 156, Unknown 26, Terminated 18, Recruiting 13, Not yet recruiting 8, Active not recruiting 7, Withdrawn 6
Phase 1220Completed 161, Unknown 20, Recruiting 17, Terminated 11, Not yet recruiting 6, Withdrawn 3, Active not recruiting 2
Early Phase 117Completed 10, Recruiting 5, Active not recruiting 1, Withdrawn 1

Follow Type 2 Diabetes: new trials by email Literature Review of Type 2 Diabetes trials Research Report on Type 2 Diabetes

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients
MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention - Type 2 Diabetes, Medication Adherence
Not applicableNot yet recruitingUniversity of Alabama at Birmingham452029-05-012026-05-20
Implementation Support for HEARTS-Based Hypertension and Diabetes Care in Guatemala
HEARTS implementation support, Routine HEARTS implementation - Hypertension (HTN), Type 2 Diabetes
Not applicableNot yet recruitingUniversity of Michigan14402027-10-012026-11-12
South Asians With Type 2 Diabetes at Risk for Depression
CHW-led T2D Intervention - Type 2 Diabetes
Not applicableNot yet recruitingNYU Langone Health1002027-08-012026-05-19
Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health
INTEGRATE-CHW, Usual Care - Hypertension (HTN), CKD - Chronic Kidney Disease
Not applicableNot yet recruitingFlorida International University2002027-07-152026-11-05
Tracking Income Dynamics and Everyday Health Study
Preventative health review invitation early in SNAP cycle, Financial counseling invitation early in the SNAP cycle, Aim 3 follow-up call early in the SNAP period - HIV, Hypertension
Not applicableNot yet recruitingUniversity of Pennsylvania4002027-03-012026-10-19
Mindful Eating and Mindful Movement for Persons With Type 2 Diabetes Mellitus
Standard of Care Diet and Exercise Group, Mindful Eating and Mindful Movement (MEMO) Group - Type 2 Diabetes
Not applicableNot yet recruitingNortheastern University602027-03-012026-09-18
Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes
Continuous Glucose Monitoring (CGM), Adaptive dietary intervention (GEM) - Type 2 Diabetes
Not applicableNot yet recruitingNYU Langone Health1202027-02-012026-08-13
Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes
Insulin icodec - Type 2 Diabetes
Phase 4Not yet recruitingXi'an International Medical Center Hospital4622027-01-012026-08-05
Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients
Metformin, Val, Cel and Met XR Low, Val, Cel and Met XR High - Type 2 Diabetes, High Blood Pressure
Phase 1 / Phase 2WithdrawnARKAY Therapeutics2026-12-102026-07-16
Efficacy of Topical Lidocaine Gel vs. Oral Duloxetine for Painful Diabetic Peripheral Neuropathy
Topical Lidocaine 2% Gel, Duloxetine (60 MG) - Painful Diabetic Neuropathy (PDN), Diabetic Neuropathies
Phase 4Not yet recruitingWah Medical college , POF hospital802026-12-012026-09-02
The LifeMeds Cohort
Multimorbidity, Cancer
Not yet recruitingTilburg University20002026-12-012026-09-29
Relacorilant in Patients With Poorly Controlled Type 2 Diabetes and Autonomous Cortisol Secretion
Relacorilant - Type 2 Diabetes, Hypercortisolism
Phase 1 / Phase 2Not yet recruitingThe University of Texas Health Science Center at San Antonio342026-12-012026-11-09
Effect of Interactive Video-Based Self-Management Education in Adults With Type 2 Diabetes
Interactive video training, Standard Nursing Care - Type 2 Diabetes, Outpatient
Not applicableNot yet recruitingAbant Izzet Baysal University602026-11-302026-10-09
Peer Support and Remote Patient Monitoring for Black Adults With Type 2 Diabetes
PROMOTE, DSMES - Type 2 Diabetes
Not applicableNot yet recruitingUniversity of Alabama at Birmingham2002026-11-302026-10-30
A Study to Learn More About How Well Finerenone Works in Real-world in People With Type 2 Diabetes and Chronic Kidney Disease in Primary Care (IMSS= Instituto Mexicano Del Seguro Social)
Finerenone - Type 2 Diabetes, Chronic Kidney Disease (CKD) Stages G2 to G3b
Not yet recruitingBayer8002026-11-302026-11-12
Effect of Molar Replacement on Glycemic Control in Adults With Uncontrolled Type 2 Diabetes
Replacement of one pair of molars - Type 2 Diabetes
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris1402026-11-152026-06-24
AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both
Zenagamtide, Semaglutide, Placebo - Type 2 Diabetes
Phase 3Not yet recruitingNovo Nordisk A/S12002026-11-102026-11-12
A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both
Placebo, Zenagamtide - Type 2 Diabetes, Chronic Kidney Disease
Phase 3Not yet recruitingNovo Nordisk A/S4502026-11-102026-11-12
Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes
FreeStyle Libre 3 Plus Continuous Glucose Monitor - Continuous Glucose Monitoring, Type 1 Diabetes
Not applicableNot yet recruitingUniversity of the Pacific602026-11-042026-11-05
Efficacy of the Use of Real-time Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes and Stage 3 and 4 Chronic Kidney Disease.
Real time continuos glucose monitoring, self blood glucose monitoring - Type 2 Diabetes, Kidney Disease
Not applicableNot yet recruitingHospital Universitario San Ignacio302026-11-012026-06-25

Showing 20 of 2587. Sign in to see all of them.

Narrower conditions

Diabetes Mellitus, Type 2 (2587)  ·  Diabetes Mellitus (355)  ·  Obesity (337)  ·  Insulin Resistance (181)  ·  Motor Activity (100)  ·  Overweight (100)  ·  Cardiovascular Diseases (83)  ·  Diabetes Mellitus, Type 1 (78)  ·  Hypertension (78)  ·  Prediabetic State (62)  ·  Metabolic Syndrome (58)  ·  Renal Insufficiency, Chronic (43)  ·  Glucose Intolerance (42)  ·  Inflammation (39)  ·  Dyslipidemias (37)

Broader conditions

Nutritional and Metabolic Diseases (2584)  ·  Endocrine System Diseases (2572)  ·  Glucose Metabolism Disorders (2566)  ·  Metabolic Diseases (2561)  ·  Diabetes Mellitus (2232)  ·  Pathological Conditions, Signs and Symptoms (524)  ·  Signs and Symptoms (414)  ·  Nutrition Disorders (368)  ·  Body Weight (362)  ·  Overnutrition (362)  ·  Overweight (265)  ·  Hyperinsulinism (225)  ·  Behavior (174)  ·  Cardiovascular Diseases (167)  ·  Vascular Diseases (154)

Interventions

Metformin (135)  ·  Sitagliptin Phosphate (77)  ·  Insulin Glargine (63)  ·  dapagliflozin (61)  ·  Exercise (60)  ·  semaglutide (51)  ·  Pioglitazone (49)  ·  Exenatide (47)  ·  Liraglutide (45)  ·  saxagliptin (33)  ·  empagliflozin (32)  ·  dulaglutide (28)  ·  glimepiride (28)  ·  Diet (24)  ·  Insulin (24)

Sponsors

AstraZeneca (95)  ·  Eli Lilly and Company (54)  ·  Jiangsu HengRui Medicine Co., Ltd. (33)  ·  Novo Nordisk A/S (24)  ·  University of Aarhus (23)  ·  University of Colorado, Denver (23)  ·  Shanghai Jiao Tong University School of Medicine (20)  ·  University of British Columbia (20)  ·  Merck Sharp & Dohme LLC (19)  ·  The University of Texas Health Science Center at San Antonio (19)  ·  Brigham and Women's Hospital (15)  ·  Emory University (15)  ·  University Hospital, Gentofte, Copenhagen (15)  ·  Assistance Publique - Hôpitaux de Paris (13)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (13)

Countries

United States (909)  ·  China (254)  ·  Canada (199)  ·  Denmark (141)  ·  United Kingdom (133)  ·  Germany (102)  ·  South Korea (99)  ·  France (96)  ·  Italy (86)  ·  Mexico (86)  ·  Turkey (Türkiye) (66)  ·  India (65)  ·  Sweden (55)  ·  Australia (54)  ·  Poland (52)

Top investigators

Daniela Jakubowicz, MD (8)  ·  Deborah Price, MSc (7)  ·  Guillermo Umpierrez, MD (7)  ·  Ralph DeFronzo, MD (7)  ·  Xiaoying Li, MD (6)  ·  Adrian Vella, MD (5)

Results publications

PMID 38770818, PMID 26894924, PMID 38682786, PMID 39963952, PMID 27402391, PMID 27461213, PMID 33368935, PMID 41591636, PMID 22913891, PMID 27306058, PMID 27964837, PMID 29974618, PMID 30117761, PMID 31301210, PMID 33436401, PMID 33512717, PMID 34131047, PMID 34135015, PMID 35210595, PMID 36938582, PMID 18663165, PMID 18852398, PMID 19017758, PMID 19114617, PMID 20859612, PMID 21228246, PMID 21932999, PMID 23435159, PMID 23451166, PMID 24400077, PMID 24912589, PMID 25414932, PMID 25927357, PMID 26303892, PMID 26441467, PMID 27407117, PMID 27514243, PMID 27627987, PMID 29802530, PMID 29923298, PMID 29941497, PMID 29941498, PMID 30475965, PMID 30550345, PMID 30632972, PMID 30765435, PMID 31114694, PMID 31178433, PMID 31364269, PMID 31589290

NIH funding

2023 (11), 2015 (7), 2019 (7), 2025 (5), 2016 (4), R01DK024092 (4), R01HL089637 (4), 2014 (3), 2018 (3), R01HL168858 (3), UL1RR024150 (3), 2005 (2), 2008 (2), 2009 (2), P50MD017338 (2)